BioNexus Gene Lab Corp. (BGLC)

Last Closing Price: 5.34 (2025-10-13)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioNexus Gene Lab Corp. (BGLC) had Revenue of $2.26M for the most recently reported fiscal quarter, ending 2025-06-30.

Figures for fiscal quarter ending 2025-06-30
Income Statement Financials
Revenue
$2.26M
$-0.62M
$1.89M
$0.37M
$2.87M
$-0.61M
$-0.00M
$-0.62M
$-0.62M
$-0.62M
$-0.62M
$-0.62M
$-0.62M
$-0.58M
$-0.54M
1.80M
1.80M
$-0.34
$-0.34
Balance Sheet Financials
$6.38M
$1.59M
$3.04M
$9.42M
$1.76M
--
$0.14M
$1.90M
$7.52M
$7.52M
$7.52M
1.80M
Cash Flow Statement Financials
$-1.56M
$-0.04M
$-0.00M
$2.89M
$1.54M
$-1.35M
--
--
--
Fundamental Metrics & Ratios
3.63
--
--
--
--
16.28%
-27.05%
-25.73%
--
-27.26%
-27.26%
$-1.59M
--
--
--
0.24
1.56
1.07
83.81
-8.19%
-8.19%
-6.54%
-8.19%
$4.19
$-0.89
$-0.87